In the present study, we identified for the first time that JAC1, the JWA gene agonist, could inhibit the proliferation of breast cancer cells by enhancing the ubiquitin modification of HER2 at the K716 site and accelerating its degradation through SMURF1 E3 ligase. Here, HSCB is linked to breast carcinoma.